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Introduction: The utilization of the post-traumatic stress disorder (PTSD) diagnostic
spectrum is currently being debated to categorize psychological adjustment in cancer
patients.
The aims of this study were to: (1) evaluate the presence of cancer-related traumatic
dissociative symptomatology in a sample of cancer patients; (2) examine the correlation
of cancer-related dissociation and sociodemographic and medical variables, anxiety,
depression, and post-traumatic stress symptomatology; (3) investigate the predictors of
cancer-related dissociation.
Methods: Ninety-two mixed cancer patients (mean age: 58.94, ds = 10.13) recruited from
two hospitals in northern Italy were administered a questionnaire on sociodemographic
and medical characteristics, the Karnofsky Scale to measure the level of patient activity
and medical care requirements, the Hospital Anxiety and Depression Scale (HADS) to
evaluate the presence of anxiety and depression, the Impact of Event Scale Revised (IES-
R) to assess the severity of intrusion, avoidance, and hypervigilance, and the Peritraumatic
Dissociative Experiences Questionnaire (PDEQ) to quantify the traumatic dissociative
symptomatology.
Results: 31.5% of participants report a PDEQ score above the cutoff. The results indicated
that dissociative symptomatology was positively correlated with HADS scores (HADS-
Anxiety: r = 0.476, p < 0.001; HADS-Depression: r = 0.364, p < 0.001) and with IES-R
scores (IES-R-Intrusion: r = 0.698, p < 0.001; IES-R-Avoidance: r = 0.619, p < 0.001; IES-
R- Hypervigilance: r = 0.681, p < 0.001). A stepwise regression analysis was performed
in order to find the predictors of cancer-related traumatic dissociative symptomatology.
The results converged on a three predictor model revealing that IES-R-Intrusion, IES-R-
Avoidance, and IES-R-Hyperarousal accounted for 53.9% of the explained variance.
Conclusion:These findings allow us to hypothesize a specific psychological reaction which
may be ascribed to the traumatic spectrum within the context of cancer, emphasizing the
close relationship between the origin of dissociative constituents which, according to the
scientific literature, compose the traumatic experience. Our results have implications for
understanding dissociative symptomatology in a cancer population and can help develop
clinical programs of prevention and support for patients.
Keywords: cancer, dissociative symptoms, post traumatic stress disorder, psychoncology, peritraumatic
dissociation
INTRODUCTION
Of the many life-threatening illnesses, cancer can be one of the
most stressful that a person might have to go through, in spite of
the progress in diagnosis, treatments, and screening. Although the
scientific literature (Bultz and Holland, 2006) and International
Guidelines (National Comprehensive Cancer Network [NCCN],
2013) increasingly focus on the importance of recognizing and
managing psychological distress in cancer patients, the burden
of the latter can very often still be unacknowledged and under-
diagnosed (Fallowfield et al., 2001; Söllner et al., 2001). Patients
who may overtly exhibit symptoms linked to mental distress may
not receive adequate treatment (Morasso and Tomamichel, 2005;
Guglielmucci et al., 2014), leading them to keep their emotional
problems to themselves.
From a clinical perspective, cancer has several traumatizing
aspects: it affects the quality of life and survival (Holzner et al.,
2013), as well as subjective well-being (Tessier et al., 2012; Hou and
Lam, 2014). It generates a sense of vulnerability, loss of control,
and hopelessness (Rodin et al., 2009; Sarenmalm et al., 2013), as
well as causing emotional reactions characterized by a high level
of arousal, avoidance in everyday life, and intrusive thoughts that
interfere with normal functioning (Roper, 2000).
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The link between cancer and post-traumatic stress disorder
(PTSD) has been reported in various scientific studies, even
though the investigationof life-threateningdiseases as apotentially
traumatic outcome still remains at an early stage: today, there is still
neither agreement nor a distinctive diagnostic line in common. In
the psycho-oncological literature, some studies are less favorable
regarding the possibility of cancer leading to PTSD (Mehnert and
Koch, 2007; Greimel et al., 2013; Phipps et al., 2014), while oth-
ers are more favorable (Posluszny et al., 2011; Kangas et al., 2013).
A recent meta-analysis (Abbey et al., 2014) shows how the cancer
experience is traumatic enough to induce PTSD in a significant
minority of cancer survivors.
The most critical views have reservations about the appropri-
ateness of the diagnosis of PTSD in patients with cancer. The DSM
V (American Psychiatric Association [APA], 2013), continuing
the DSM IV-TR (American Psychiatric Association [APA], 2000),
reports a classification system mainly indicated for physically
healthy patients with mental disorders.
Cancer differs from other traumatic events in several aspects:
(a) the imminence and degrees of life-threatening consequences,
because cancer is not a singular trauma and PTSD may operate
in a different way in patients diagnosed with cancer compared
to individuals with PTSD who have experienced a single trau-
matic event such as an accident or assault (Greimel et al., 2013);
(b), cancer patients commonly experience future-oriented and
anticipatory worries such as fear of recurrence linked to real-
istic and potentially life-threatening stressors (Mehnert et al.,
2009); (c) the internality of threat that may affect the per-
ception and meaning of the cancer threat, primarily in terms
of its perceived inescapability (Gurevich et al., 2002). In the
light of the foregoing, it is not possible to know in advance
the impact of the disease experience on each individual nor
is it easy to determine which answers can be placed in a
framework of normality and which in one of pathology. It
is important to reflect on what sense it makes to talk about
post-traumatic stress when faced with such events, where no
patient is ever declared “definitely cured” (Trotti and Bellani,
unpublished).
Gurevich et al. (2002) reported that among patients with newly
diagnosed cancer at an early stages only 3–4% have a full PTSD,
while 20% show subthreshold symptoms of PTSD; this is then
present in 35% of patients after treatment and in 80% of cases
of recurrence. In support of the hypothesis on the importance of
assessing the presence of post-traumatic clinical symptoms, rather
than the overall picture, Blanchard et al. (1996), Stein et al. (1997),
and Marshall et al. (2001) propose some methods for the detection
of subthreshold PTSD, taking into account the responses to stress
as located on a continuum, rather than distinguishing cases in
which it is present or not.
From this perspective, the word trauma regains its original
meaning of “wound” (τραv˜μα), used not in the sense of a singular
event, but as a “psychobiological wound,” evolved from psycho-
logical, biological, and social factors, and with different degrees
and symptom paths in developing psychological pain. The fac-
tors involved in the genesis of a PTSD symptomatology could
involve limitations of the patient’s integrative capacity, expressed,
for example, with dissociative reactions, affect dysregulation, and
persistent avoidance of traumatic memories (Nijenhuis and van
der Hart, 2011).
Our study examines the presence of processes and dissociative
states in a sample of cancer patients. It seems that dissociation
occupies an important position in the genesis of emotional mani-
festations in patients affected by cancer (Ronson, 2005). Through
a review of psycho-oncological scientific literature, we examined
some studies whose results demonstrate the existence in can-
cer patients of a relationship between trauma, dissociation, and
emotional reactions to stress (e.g., Gershuny and Thayer, 1999;
Maciejewski andPrigerson,2013). Other authors showmuchmore
critical positions, highlighting the retrospective nature of the phe-
nomena of dissociation, such as memory distortion, implemented
even before the oncological pathology (Merckelbach and Muris,
2001).
With respect to the role of memory in the genesis of dissociative
processes, Dunn et al. (1993) evaluated the information obtained
from the patients after their oncologist had given them their cancer
diagnosis, checking to what extent this was stored in their mem-
ory over the next 19 days. The results, showing that only 25% of
the information given by the medical oncologist was remembered,
allow the hypothesis of a dissociative response to receiving a diag-
nosis of cancer. In actual fact, the mnemonic gaps of the subjects
could be attributed to dissociative amnesia, or to someother deficit
related to different memory systems. However, this interpretation
must be accompaniedby caution as the researchmethodologydoes
not allow the quality of the communication between doctor and
patient to be known, the possible difficulties of understanding of
some subjects or the activation of the mechanism of denial. With
regard to themethodological limitations of various researches, and
in particular of the above-described one, it is evident that these
results undermine the traditional concept of dissociation, accord-
ing to which this has an adaptive function, since the impact of a
traumatic experience on the individual could be reduced through
compartmentalization. Today, on the contrary, some of the most
experienced clinicians in the field are putting forward a new idea
of dissociation, stating that it is due to sudden changes in the net-
works of autobiographical memory (Ronson, 2005). To explore
this concept of dissociation and its genesis, we herein report some
research which, thanks to functional magnetic resonance imaging,
has shown that at the time of communication of the diagnosis
the brain areas involved in emotional responses are activated,
interfering with the adequate processing of the information in
the memory (Greene et al., 2001). In this regard, a pioneering
research by Weisman and Worden (1976) conducted on 120 can-
cer patients showed the presence of peritraumatic dissociative
symptoms, such as manifestations of alienation, depersonaliza-
tion, derealization, distortion in perception of the self, and of the
surrounding environment. Other authors have investigated post-
traumatic reactions in cancer patients highlighting that, of the
items in the IES, the one with the highest mean score is precisely
the one that describes the perception of the experience as unreal
(Tjemsland et al., 1996). Inevitably, cancer experience involves a
fracture of the sense of continuity of the self and of one’s own
existence. Indeed, many patients experience feelings of disbelief,
numbness, unreality, out-of-body experiences, and sometimes
even a feeling of a sudden inability to recognize, reporting that
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they are under the impression that their own body, feelings, and
personality have changed forever (Brennan, 2001).
In the light of the above, the aims of this study were to:
(1) evaluate the presence of cancer-related traumatic dissociative
symptomatology in a sample of cancer patients; (2) examine the
correlation of cancer-related dissociation and sociodemographic
and medical variables, anxiety, depression, and post-traumatic
stress symptomatology; and (3) investigate the predictors of
cancer-related dissociation.
MATERIALS AND METHODS
PARTICIPANTS
The sample consisted of 92 general cancer patients (mean age
58.94, SD = 10.13; range 35–81 years) corresponding to the 92
questionnaires returned out of a total of 190 delivered. They
were recruited from two hospitals in northern Italy: 53.3% of
the returned questionnaires came from the centro oncologico ed
ematologico subalpino (COES), Subalpine Center for Oncology
and Hematology in Turin (N = 49) and 46.7% from the Ospedale
Maggiore della Carità di Novara (Charity General Hospital) in
Novara (N = 43). The study was approved by the Institutional
Review Board at each participating institution and participating
patients completed the informed consent process.
The sociodemographic variableswere detected alongwith those
relating to the state of the oncological pathology (see Table 1). The
sample consisted of 55.4% women and 44.6% men.
As regards their family status, 71.8% of the subjects were mar-
ried (N = 56), 18.5% separated or divorced (N = 17), and 5.4%
single or unmarried (N = 5), while 15.2% did not specify their
marital status (N = 14). The cancers diagnosed included: lung,
breast, gastro-intestinal, liver, skin, lymph node, bone, colon-
rectum, urogenital, ovarian. With regard to the variables related
to neoplastic disease, the sample was distributed as follows (see
Table 2): 21.7% of patients were at stage I of the disease, 10.9%
at stage II, 15.2% at III, and 32.6% at IV; while 78.3% had had
surgery, and 82.6% chemotherapy.
The time elapsed since diagnosis ranged from 1 to 108 months,
with an average of 15.54 months and SD = 16.46. On the basis of
the data obtained using the Karnofsky Performance Status Scale,
the psycho-physical state of the subjects on the whole was good,
since with a range from 60 to 100 in the sample, the mean score
was equal to 88.80%, with SD = 12.3.
MATERIALS
The Karnofsky Performance Status Scale (KPS; Karnofsky and
Burchenal, 1949) is a scale of health assessment in patients with
malignant tumors, which evaluates the quality of life of a cancer or
terminal patient through parameters related to activity limitation,
self-care and self-determination. It measures the patient’s physi-
cal condition, performance, and prognosis following a therapeutic
intervention.
The results may vary by a percentage ranging from 0 to 100%,
where 100% reflects a good state of health, and 0% represents
death.
The Hospital Anxiety and Depression Scale (HADS; Zigmond
and Snaith, 1983) is a self-assessment questionnaire developed
to detect states of anxiety and depression in patients suffering
Table 1 | Summary chart showing the demographic descriptions of
the sample.
N %
Gender
Male 41 44.6
Female 51 55.4
Family status
Married 59 60.9
Not married 5 5.4
Divorced 17 18.5
No answer 14 15.2
Table 2 | Summary chart showing the clinical descriptions of the
sample.
N %
Stage of the disease
I 20 21.7
II 10 10.9
III 14 15.2
IV 30 32.6
No answer 18 19.6
Cancer diagnosis
Lung 8 8.7
Breast 24 26.1
Gastro-intestinal 21 22.8
Liver 7 7.6
Skin 1 1.1
Lymph node 2 2.2
Bone 4 4.3
Colon-rectum 12 13
Urogenital 4 4.3
Ovarian 3 3.3
No answer 5 5.4
Chemo-therapy
Yes 76 82.6
No 14 15.2
No answer 2 2.2
Surgery
Yes 72 78.3
No 18 19.6
No answer 2 2.2
from organic diseases. This tool consists of two 7-item scales, one
for anxiety assessment (HADS-A) and the other for depression
assessment (HADS-D). For each statement, the patient is asked
to indicate which of four possible options best describes his/her
emotional state by means of a score between 0 and 3, in which 0
represents absence of the symptom and 3 its maximum severity
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(Bjelland et al., 2002). The score in both scales is the result of the
sum of the scores assigned by the individual to each item.
The Impact of the Event Scale–Revised (IES-R; Weiss and Mar-
mar, 1997; Italian version Giannantonio, 2003) aims to detect the
presence of symptoms resulting from exposure to the specific trau-
matic event in the week before its administration. It investigates
the ways the PTSD typically responds, since its three subscales
evaluate the level of Intrusion (IES-R 1), Avoidance (IES-R 2),
and Hyperarousal (IES-R 3) perceived by patient. The IES-R con-
sists of 22 items on a four-score scale where 0 stands for “not at
all,” 1 for “a little bit,” 2 for “moderately,” 3 for “quite a bit,” and
4 for “extremely.” The score is obtained by combining the three
subscales, whose respective ranges are Intrusion, 0–32; Avoidance,
0–32; and Hyperarousal, 0–24. The cut-off is set at 33, while a
score between 24 and 29 is taken as a sign of a partial PTSD
and, finally, a score equal to or greater than 37 indicates a high
presence of post-traumatic symptomatology (Weiss and Marmar,
1997).
The Peritraumatic Dissociative Experiences Questionnaire
(PDEQ; Marmar et al., 2004) was developed with the purpose of
investigating the dissociative component in response to a trau-
matic event. It therefore includes the detection of symptoms such
as derealization, depersonalization, amnesia, altered perception
of time, confusion, and impaired consciousness. It consists of
10 items, each of which has five alternative answers, whose score
ranges between 0 (“not at all true”) and 5 (“extremely true”).
The total score is obtained by adding up the scores obtained for
individual items and thus lies between 0 and 50.
RESULTS
For the statistical analysis, the Software Statistical Package for
Social Science (SPSS) version 21.0 was used. The Pearson test and
Student’s t-test were used in order to evaluate the correlation and
to compare means between PDEQ scores and sociodemographic
and clinical variables. A stepwise multiple linear regression model
was used to analyze the relationship between the dependent vari-
able (PDEQ scores) whenever any changes occurred in the clinical
and socio-demographic conditions of the variables related to the
psychological state. Values of p ≤ 0.05 were considered statistically
significant.
ANXIOUS AND DEPRESSIVE SYMPTOMATOLOGY
The anxious and depressive symptomatology was assessed by the
HADS.
The average of the scores obtained in our sample is close to
the cut-off score but still below the threshold. With regard to anx-
ious symptomatology, the subjects obtain a score between 0 and
17, with an average of 7.07 (SD = 4.20), while with regard to the
presence of depressive symptomatology, the results show a score
between 0 and 19, with an average of 6.97 (SD = 4.87). The overall
score resulting from the sum of the scores related to the two scales
lies in a range between 1 and 33, with a mean score of 14.04
(SD = 8.45). 54.3% of the subjects achieved HADS scores indicat-
ing the presence of anxiety symptoms (N = 50), compared to the
depressive symptoms found in 60.9% of the subjects (N = 56).
Finally, considering the total score, it can be noted that in 55.4%
of cases (N = 51) there is a score above the cut-off.
POST-TRAUMATIC SYMPTOMATOLOGY
29.3% of the subjects (N = 27) reported mild post-traumatic
symptomatology, while 32.6% had symptoms of moderate sever-
ity (N = 30). The analysis of the three subscales investigating the
extent of intrusion, avoidance, and hyperarousal reported the fol-
lowing results: IES-R 1 (intrusion) scores in a range between 0 and
28,with ameanof 11.3 (SD=6.62); IES-R2 (avoidance) scores in a
rangebetween0 and26,with ameanof 10.50 (SD=6.09); and IES-
R 3 (hyperarousal) scores in a range between 0 and 19, with amean
of 7.28 (SD = 5.25). Finally, the IES-R total score lies in a range
between 1 and 73, with a mean value of 28.89 and SD = 16.35.
DISSOCIATIVE SYMPTOMS
The presence of peritraumatic dissociative symptoms in our
sample was investigated through the PDEQ questionnaire. In par-
ticular, scores above the cutoff were found in 31.5% of subjects
(N = 29). The scores obtained ranged between 8 and 40, with a
mean score of 18.58 (SD = 8.27).
PREDICTION OF PERITRAUMATIC DISSOCIATION
Table 3 presents the correlation coefficients calculated between
all the potential independent variables and PDEQ scores in order
to select the optimal set of potential predictors of peritraumatic
dissociation. This method was adapted from the methodology
developed by Blanchard et al. (1996), which was used in the first
systematic attempt to predict post-traumatic stress symptomatol-
ogy following trauma in motor vehicle accidents.
No linear correlation was found between the presence of
dissociative symptoms and the socio-demographic and medical
variables (months after diagnosis and KPS score). On the con-
trary, the use of the Student’s t-test to compare the means of
two independent samples highlighted the presence of a higher
mean score relating to the scale of dissociation in patients receiv-
ing chemotherapy (N = 76, mean = 19.55, SD = 8.47) compared
with patients who were not (N = 14, mean = 14.43, SD = 5.51;
p ≤ 0.05). Having undergone surgery in relation to an oncologi-
cal pathology does not mean higher PDEQ scores will be detected
(p ≥ 0.05).
The results indicated that dissociative symptomatology
was positively correlated with HADS scores (HADS-Anxiety:
r = 0.476, p< 0.001; HADS-Depression: r = 0.364, p< 0.001) and
with IES-R scores (IES-R-Intrusion: r = 0.698, p < 0.001; IES-R-
Avoidance: r = 0.619, p< 0.001; IES-R-Hypervigilance: r = 0.681,
p <0.001).
On the basis of the trauma literature, it was also deemed neces-
sary to control the effects of demographic variables and treatment
complications following diagnosis of cancer.
Table 3 presents a summary of the variables that were
significantly correlated with PDEQ scores.
A simultaneous multiple regression was conducted using the
five variables correlating most strongly with the PDEQ scores
(HADS-A, HADS-D, IES-R 1, IES-R 2, and IES-R 3).
In Table 4, the tolerance values smaller than 0.50 and VIF
greater than 2 indicate suspected collinearity for the predictors.
However, the values were acceptable with reference to the litera-
ture (e.g., Rogerson, 2001; Pan and Jackson, 2008), although the
results should be considered with caution.
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Table 3 | Correlations between the sociodemographic and clinical
variables, and the dissociative peritraumatic symptomatology.
Variable Peritraumatic dissociative
experiences questionnaire
(PDEQ) score
Months after diagnosisa −0.169
Stage of diseaseb 0.149
Agea −0.144
KPS −0.041
HADS-A 0.476**
HADS-D 0.364**
IES-R 1 0.698**
IES-R 2 0.619**
IES-R 3 0.681**
IES-R total score 0.729**
aN = 90; bN = 74; **p < 0.01.
Table 4 | Collinearity statistics.
Model Tolerance VIF
1 IES-R 1 1.000 1.000
2 IES-R 1 0.298 3.360
IES-R 3 0.298 3.360
3 IES-R 1 0.257 3.892
IES-R 3 0.288 3.476
IES-R 2 0.485 2.063
The Durbin-Watson statistic, its value (2.398) slightly outside
the range 1.5−2.2 suggested as acceptable, would seem to indi-
cate a slight autocorrelation between errors and therefore suggests
caution in interpreting the results. Through the stepwise regres-
sion, the model was perfected in three subsequent steps, each time
increasing the number of predictors (at first only IES-R 1, then
R3 and finally IES-R 1-IES, IES-R 3, and IES-R 2). As can be
seen in Table 5, there is a progressive improvement in the data
adjustment to the model as the multiple regression progresses:
the final value of the coefficient of determination R2 = 0.539,
adjusted to 0.523 (the small difference between the two indi-
cates the absence of redundancy between the predictors) means
that this model accounts for more than 50% of the dependent
variables.
DISCUSSION
The majority of the sample group, about 62% of the subjects
(N = 57), reported at least a mild form of post-traumatic
symptomatology and 31.5% (N = 29) reported peritraumatic
dissociative symptoms. Consistent with the results of Kangas
et al. (2002), Hodgkinson et al. (2007), our findings highlight
the absence of linear correlation between the presence of post-
traumatic symptomatology and the socio-demographic and med-
ical condition. With respect to this last point, in the literature
it has been hypothesized that PTSD symptomatology is related
to more advanced stages of the disease and types or length of
cancer treatments, but the research findings are still ambigu-
ous (Andrykowski and Kangas, 2010). In line with the studies of
Granieri et al. (2013) and Pérez et al. (2014), we see our findings as
underlining the role of subjectivity, resilience factors and personal
history of the patient’s life, rather than dwelling on the objectivity
of the cancer event in itself.
The relationship found between the dissociation scores and
the parameters related to psychological complications (Anxiety,
Depression, Intrusion, Avoidance, and Hyperarousal) can be seen
as an indicator of suffering in cancer patients, in both the man-
agement of feelings and the creation of new meanings generated
around the disease condition. Indeed, if dissociation can pro-
tect an individual from overwhelming emotions (van der Hart
et al., 2004), it may also impede long-term recovery by preventing
emotional processing and integration into the explicit memory of
potentially traumatic memories, generating distortion or narra-
tive fractures which may contribute to maintaining the symptoms
in a circular way (van der Kolk and Fisler, 1995; Brown et al.,
2014).
The linear regression model showed that 53.9% of the variance
of our 3-factor model (Intrusion, Avoidance, and Hyperarousal)
seems to be related to the post-traumatic symptomatology.
As can be seen from our results, only the three traumatic sub-
scales had significant positive regression weights, indicating that
patients with higher scores on these scales were expected to have
higher dissociation scores. The sociodemographic and clinical
Table 5 |Variables identified by stepwise regression analysis as predicting PDEQ scores.
Model 1 Model 2 Model 3
Variable B SE B B B SE B B B SE B B
IES-R 1 0.869 0.095 0.696** 0.525 0.170 0.421** 0.391 0.180 0.313*
IES-R 3 0.515 0.214 0.329* 0.436 0.214 0.278*
IES-R 2 0.286 0.142 0.212*
R2 0.485 0.517 0.539
F for change in R2 82.872** 5.788* 4.071*
*p < 0.05; **p < 0.01.
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variables did not contribute to the multiple regression model.
These results allow us to hypothesize a specific psychological reac-
tion which may be ascribed to the traumatic spectrum within the
context of cancer, emphasizing the close relationship between the
originof dissociative constituentswhich, according to the scientific
literature, compose the traumatic experience.
It is important to note that our study, like most researches in
the context of PTSD and cancer (Andrykowski and Kangas, 2010),
has used a cross-sectional design. Tautologically, this kind of study
does not allow a longitudinal perspective, precluding the detection
of different threats across disease and treatment progressions, and
limiting what we can conclude about the direction of causality
between the genesis of PTSD symptomatology and dissociation.
For this reason, in agreement with Breh and Seidler (2007), it
would be advisable also in the field of psycho-oncology to address
future research to a clearer conceptualization of peritraumatic dis-
sociation, as it is still unclear whether the latter is a symptom, a
predictor or something else, in the framework of psycho-traumatic
stress syndrome.
A second limitation regards the generalizability of the results.
Since the number of cancer patients was limited and the sample
was composed of volunteers, the findings may not be valid for the
whole population. Future studies are needed to detect the aspects
that can influence the etiopathogenesis of dissociation, as well as
PTSD symptomatology during the cancer journey, referring to a
diverse cancer population, and to a different stage of the disease
and treatments. Finally, part of the dissociative symptomatology
reported by patients (e.g., insomnia, irritability, fatigue) may be
related to anti-tumor therapy. This variable has not been taken into
account in this study, but it is important for researchers and clini-
cians to be aware, as observed byKangas et al. (2002), that there are
also differential diagnostic issues arising from cancer or treatment
which induce physical symptoms that overlap with apparently
dysfunctional psychological responses.
Despite these limitations and given the lack of longitudinal
studies evaluating dissociative processes and PTSD symptoma-
tology in the cancer context, our work provides a valuable
perspective of these phenomena, helping clinicians in the planning
phase of prevention and intervention programs, which should
give patients the opportunity to openly express psychological
and traumatic aspects of their experience. Specific and accurate
psychological support can lead patients to a better assimilation
of distressing unintegrated memories into coherent narratives,
and to develop efficient coping strategies helping the patients to
become better at recognizing and meeting their emotional and
meaning-related needs.
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